在血管炎症和动脉样硬化心血管疾病中,专门的亲解决媒介
Gabrielle Fredman1, Charles N Serhan2
1Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, USA. fredmag@amc.edu.
Nature reviews. Cardiology
|January 12, 2024
概括
炎症解决对健康至关重要,防止与动脉样硬化等疾病相关的慢性炎症. 专业的亲解决调解者通过促进愈合,为治疗心血管疾病提供潜在的治疗点.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症解消是对健康至关重要的活跃过程,由专门的促解消调解者调节.
- 如果不及时解决炎症,可能导致慢性炎症,与诸如动脉样硬化心血管疾病等疾病有关.
- 了解解决失败的机制和确定心血管疾病中不解决炎症的生物标志物是关键的未满足需求.
研究的目的:
- 审查证据,将无法解决的炎症与动脉样硬化联系起来.
- 在治疗动脉样硬化心血管疾病方面探索专门的亲解决调解者的治疗潜力.
- 确定关键问题,并为未来的动脉样硬化预防和治疗研究提供框架.
主要方法:
- 对不断积累的科学证据进行审查.
- 分析了专门的解决方案调解员的作用.
- 讨论治疗策略和疾病机制.
主要成果:
- 无法解决的炎症在动脉样硬化病变发生过程中起着重要作用.
- 专门的亲解决调解者证明了对动脉样硬化心血管疾病的治疗潜力.
- 目前的理解留下了关于最佳治疗策略和潜在疾病机制的开放问题.
结论:
- 有效的炎症解决对于预防动脉样硬化等慢性炎症性疾病至关重要.
- 专门的亲解决调解者代表了动脉样硬化心血管疾病的有前途的治疗途径.
- 需要进一步的研究来阐明动脉样硬化症的机制和优化治疗干预措施.
相关概念视频
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Vascular Resistance
4.0K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
4.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Antihypertensive Drugs: Vasodilators
526
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
526
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
183
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
183


